Frontlight ResearchEarly access
Trial site
Fred Hutch Cancer Research
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Myeloproliferative neoplasms1 trial
- Prostate cancer1 trial
- Phase
- Phase 22 trials
- Phase 1/21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals4 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
Site data: ClinicalTrials.govUpdated 14 Nov 2026